TROPiCS-02 Subgroup Analysis by Age
TROPiCS-02 Subgroup Analysis by Age: Sacituzumab Govitecan vs Treatment of Physician’s Choice in HR+/HER2- MBC

Released: December 09, 2023

Activity

Progress
1
Course Completed